Bank Of New York Mellon Corp Pacific Biosciences Of California, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $5.47 Million - $10.8 Million	964,042 New	964,042 $7.89 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $8.57 $452,570 - $986,904	115,158 Added 13.59%	962,390 $5.59 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $602,244 - $1.56 Million	-149,812 Reduced 15.03%	847,232 $3.75 Million
Q1 2022 May 11, 2022	SELL	$8.43 - $20.9 $81,728 - $202,625	-9,695 Reduced 0.96%	997,044 $9.07 Million
Q4 2021 Feb 11, 2022	BUY	$19.26 - $30.08 $225,727 - $352,537	11,720 Added 1.18%	1,006,739 $20.6 Million
Q3 2021 Nov 12, 2021	BUY	$24.86 - $35.02 $1.02 Million - $1.44 Million	41,230 Added 4.32%	995,019 $25.4 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $206,096 - $332,896	-9,242 Reduced 0.96%	953,789 $33.4 Million
Q1 2021 May 13, 2021	SELL	$26.38 - $51.15 $1.11 Million - $2.15 Million	-41,989 Reduced 4.18%	963,031 $32.1 Million
Q4 2020 Feb 09, 2021	SELL	$10.5 - $28.5 $187,299 - $508,383	-17,838 Reduced 1.74%	1,005,020 $26.1 Million
Q3 2020 Nov 12, 2020	BUY	$3.61 - $9.87 $4,674 - $12,781	1,295 Added 0.13%	1,022,858 $10.1 Million
Q2 2020 Aug 12, 2020	SELL	$2.65 - $4.03 $126,169 - $191,872	-47,611 Reduced 4.45%	1,021,563 $3.52 Million
Q1 2020 May 06, 2020	BUY	$2.36 - $5.26 $2,024 - $4,513	858 Added 0.08%	1,069,174 $3.27 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $184,312 - $223,178	-40,068 Reduced 3.61%	1,068,316 $5.49 Million
Q3 2019 Nov 07, 2019	BUY	$4.99 - $6.16 $2.27 Million - $2.8 Million	454,281 Added 69.45%	1,108,384 $5.72 Million
Q2 2019 Aug 12, 2019	BUY	$5.92 - $7.41 $71,122 - $89,023	12,014 Added 1.87%	654,103 $3.96 Million
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $148,158 - $161,231	21,788 Added 3.51%	642,089 $4.64 Million
Q4 2018 Feb 11, 2019	BUY	$3.99 - $7.82 $295,267 - $578,695	74,002 Added 13.55%	620,301 $4.59 Million
Q3 2018 Nov 09, 2018	BUY	$3.52 - $5.55 $205,599 - $324,169	58,409 Added 11.97%	546,299 $0
Q2 2018 Aug 06, 2018	BUY	$2.11 - $3.92 $106,974 - $198,740	50,699 Added 11.6%	487,890 $1.73 Million
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $38,509 - $60,675	18,785 Added 4.49%	437,191 $897,000
Q4 2017 Feb 09, 2018	BUY	$2.59 - $5.44 $1.08 Million - $2.28 Million	418,406	418,406 $1.11 Million

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33.4M
Shares

$65.1 Million
0.54% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$46 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$45.6 Million
6.35% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

20.3M
Shares

$39.6 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$34.4 Million
0.0% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account